IBionext

IBionext operates as a specialized venture builder and growth fund dedicated to the healthtech sector, transforming innovative medical technologies into viable commercial products. Since its founding in 2012, the organization has established a comprehensive ecosystem for nurturing startups from their earliest stages through significant growth phases. Their dual approach as both company builder and investment fund provides portfolio companies with not only capital but also strategic guidance, operational support, and industry connections essential for success in the complex healthcare market.

The fund's track record demonstrates remarkable success, having created nine healthcare technology companies that have collectively secured over 600 million Euros in funding. This substantial capital raising achievement underscores IBionext's credibility within the investment community and their ability to identify promising healthcare innovations. Beyond financial metrics, IBionext has contributed significantly to the innovation economy by generating more than 370 highly-skilled positions across their portfolio companies, creating meaningful employment opportunities for specialized talent in the healthcare and technology sectors.

IBionext's methodology follows a three-stage approach beginning with "Spot" - where they leverage their ecosystem to identify, evaluate, and mature promising healthcare technologies with significant market potential. The second phase, "Boost," involves assembling experienced professionals to transform these disruptive healthcare concepts into structured startups with solid foundations, while simultaneously securing initial and follow-on financing rounds. This hands-on company building approach differentiates IBionext from traditional venture capital firms that typically engage after company formation.

In the final "Grow" stage, IBionext provides ongoing strategic support to accelerate their portfolio companies' development trajectories. This includes assistance with international expansion, additional fundraising, strategic partnerships, and potential exit strategies. The fund's ultimate objective is to develop global healthcare champions that deliver significant returns for investors while addressing critical medical needs through innovative technologies. IBionext's comprehensive venture building model has positioned them as a distinctive player in the European healthtech investment landscape, bridging the gap between academic innovation and commercially viable healthcare solutions.